Eli Lilly Savings Program for Mounjaro and Zepbound
Last updated: April 1, 2026
Quick Answer: The Eli Lilly Savings Program for Mounjaro and Zepbound offers eligible patients multiple ways to reduce their monthly costs significantly. Commercially insured patients can pay as little as $25 per month with the Savings Card, self-pay patients can access Zepbound through LillyDirect for $299 to $449 per month, and Medicare beneficiaries now qualify for a $50/month cap under a new White House agreement effective April 1, 2026. [1][6]
Key Takeaways
- 💊 Commercially insured patients can use the Zepbound or Mounjaro Savings Card to pay as little as $25/month on eligible prescriptions [6]
- 🏥 Medicare beneficiaries now qualify for Zepbound at $50/month through a new federal pricing agreement, effective April 1, 2026 [1]
- 💻 Self-pay patients can order Zepbound multidose pens through LillyDirect for $299–$449/month, no insurance required [1]
- 🚫 Government insurance holders (Medicare, Medicaid, TRICARE, VA) are not eligible for the commercial Savings Card [3]
- 💰 Uninsured patients without LillyDirect access can use the Savings Card to cap Zepbound costs at $499/month for single-dose pens [3]
- 📦 The new Zepbound multidose KwikPen (announced February 23, 2026) holds four doses in one reusable device, reducing per-dose costs [2]
- 💊 Orforglipron, Lilly’s new once-daily oral GLP-1, will be available at $149–$399/month through LillyDirect pending FDA approval [1]
- 📋 Savings Card coverage applies to 1-month, 2-month, or 3-month supply fills, with a month defined as 28 days [6]
- 🔄 Mounjaro (tirzepatide for type 2 diabetes) is also available on LillyDirect at a 50–60% discount off list price for self-pay patients [4]
Most people searching for GLP-1 affordability tips land on articles that skim the surface, list a phone number, and call it a day. This article does not do that.
The Eli Lilly Savings Program for Mounjaro and Zepbound changed significantly in 2026, and if you’re still using 2024 information to make your decisions, you could be leaving hundreds of dollars on the table every single month.
Below, you’ll find every current savings pathway, who qualifies for each one, exactly what each program costs, and the mistakes that get people rejected. Read through before you call your pharmacy.
How Does the Eli Lilly Savings Program for Mounjaro and Zepbound Actually Work?
The Eli Lilly Savings Program for Mounjaro and Zepbound is not a single program. It’s a collection of overlapping savings pathways, each with different eligibility rules, cost caps, and access channels. Knowing which one applies to your situation is the difference between paying $25 and paying $1,200 for the same medication.
Here’s a breakdown of the four main pathways in 2026:
| Savings Pathway | Who Qualifies | Monthly Cost |
|---|---|---|
| Savings Card (insured) | Commercial insurance only | As low as $25 [6] |
| Savings Card (uninsured) | No government insurance | Capped at $499 [3] |
| LillyDirect Self-Pay | Self-pay, no insurance required | $299–$449 [1] |
| Medicare $50 Cap | Medicare Part D enrollees | $50 [1] |
| Medicaid Expansion | State Medicaid programs | Varies by state [1] |
Important constraint: You cannot stack these programs. Choose the one that matches your insurance status. Government insurance holders (Medicare, Medicaid, TRICARE, VA) are excluded from the commercial Savings Card entirely. [3]
Quick rule: If you have commercial insurance, use the Savings Card first. If you’re uninsured or self-pay, LillyDirect is almost always the better deal than the $499 uninsured Savings Card cap.
Who Qualifies for the Zepbound and Mounjaro Savings Card?
The Savings Card is available to patients with commercial (private) insurance who have a valid prescription for Zepbound or Mounjaro. It is not available to anyone enrolled in a government-funded insurance program.
You qualify if you:
- Have commercial health insurance (employer-sponsored, marketplace, or private plan)
- Have a valid prescription from a licensed U.S. healthcare provider
- Are filling at a participating U.S. pharmacy
- Are not enrolled in Medicare, Medicaid, TRICARE, or any VA program [3][6]
You do not qualify if you:
- Are on Medicare (any part)
- Are on Medicaid
- Are a TRICARE or VA beneficiary
- Are outside the United States
For uninsured patients who don’t qualify for LillyDirect, the Savings Card still caps Zepbound costs at $499/month for single-dose pens. That’s not cheap, but it’s significantly less than the $1,000+ retail price. [3]
For a deeper look at how tirzepatide pricing works across different scenarios, see our complete guide to tirzepatide costs in 2026.
What Is the LillyDirect Self-Pay Program and How Much Does It Cost?
LillyDirect is Eli Lilly’s direct-to-patient pharmacy platform. It lets self-pay patients order Zepbound (and now Mounjaro) at significantly reduced prices without needing insurance approval.
Current LillyDirect pricing for Zepbound multidose pens (as of April 1, 2026):
- Lowest dose: $299/month
- Mid-range doses: $349–$399/month
- Higher maintenance doses: $449/month [1]
These prices reflect a $50 reduction from the previous pricing of $349–$499, announced as part of the White House agreement. [1]
The new Zepbound multidose KwikPen (launched February 23, 2026) is a reusable device that holds four doses, covering one full month of once-weekly injections. This design reduces waste and cost compared to four separate single-dose pens. [2]
Mounjaro (tirzepatide prescribed for type 2 diabetes) is also now available on LillyDirect at 50–60% off current list prices for self-pay patients. [4]
For context on how these prices compare to other GLP-1 options, check out our best affordable GLP-1 weight loss programs guide.
What Changed for Medicare Patients in 2026?
This is the biggest update of 2026. Medicare beneficiaries with obesity or related health conditions can now access Zepbound at $50/month, effective April 1, 2026, through a new agreement between Eli Lilly and the U.S. government using a Most Favored Nation (MFN) pricing model. [1][4]
What this covers:
- Zepbound multidose pen (full month’s supply, four doses per pen)
- Orforglipron (Lilly’s once-daily oral GLP-1, pending FDA approval)
- Available through participating Medicare Part D drug plans [4]
Who this applies to:
- Medicare beneficiaries with obesity
- Medicare beneficiaries with obesity-related comorbidities (such as type 2 diabetes, hypertension, or sleep apnea)
What’s still pending: Orforglipron’s $50 Medicare pricing is contingent on FDA approval. Lilly has applied for expedited approval through the Commissioner’s National Priority Voucher program. [1]
States can also expand access to both Zepbound multidose pens and orforglipron through their Medicaid programs under this agreement, though coverage will vary by state. [1]
If you’re on Medicare and have been paying full price for Zepbound, contact your Part D plan immediately. Coverage under this agreement began April 1, 2026.
For a broader comparison of GLP-1 options without insurance, see our GLP-1s without insurance costs and best options guide.
How Do You Enroll in the Eli Lilly Savings Program for Mounjaro and Zepbound?
Enrollment depends on which savings pathway you’re using. Here’s the step-by-step process for each.
For the Savings Card (commercially insured or uninsured):
- Get a valid prescription from your doctor for Mounjaro or Zepbound
- Visit zepbound.lilly.com/savings or mounjaro.lilly.com/savings-resources
- Complete the online enrollment form (takes about 5 minutes)
- Download or print your Savings Card
- Present the card at a participating pharmacy when filling your prescription [5][6]
For LillyDirect (self-pay):
- Visit LillyDirect.com and create an account
- Select Zepbound or Mounjaro
- Connect with a telehealth provider through the platform (if you don’t have an existing prescription)
- Complete your order; medication ships directly to your door
For Medicare $50 cap:
- Confirm your Part D plan participates in the new pricing agreement
- Contact your plan directly or call 1-800-MEDICARE for guidance
- Fill your Zepbound prescription through your participating plan [4]
Common mistake: Many patients try to use the commercial Savings Card at the pharmacy without activating it online first. The card must be registered before use. [6]
How Does the Eli Lilly Savings Program for Mounjaro and Zepbound Compare to Competitor Programs?
Lilly’s savings programs are currently among the most structured in the GLP-1 space, but they’re not the only option. Here’s how they stack up against Novo Nordisk’s programs for Ozempic and Wegovy.
| Feature | Lilly (Mounjaro/Zepbound) | Novo Nordisk (Ozempic/Wegovy) |
|---|---|---|
| Insured copay minimum | $25/month [6] | ~$25/month |
| Self-pay direct pricing | $299–$449/month [1] | Not available directly |
| Medicare cap | $50/month (April 2026) [1] | Not yet announced |
| Oral GLP-1 option | Orforglipron (pending) [1] | Rybelsus (for diabetes only) |
| Multidose pen | Yes (4 doses/pen) [2] | No |
Lilly’s LillyDirect self-pay option and the new Medicare $50 cap give it a meaningful edge for patients in those two categories. For commercially insured patients, the programs are roughly equivalent.
For a head-to-head clinical comparison of the medications themselves, see our semaglutide vs. tirzepatide weight loss comparison.
What Is Orforglipron and How Does It Fit Into Lilly’s Savings Programs?
Orforglipron is Eli Lilly’s once-daily oral GLP-1 receptor agonist, currently awaiting FDA approval. Unlike injectable GLP-1s, it comes in pill form, which eliminates the injection barrier for many patients.
Planned pricing through LillyDirect:
- Lowest dose: $149/month
- Additional doses: up to $399/month [1]
Medicare pricing (pending FDA approval): $50/month under the same White House agreement as Zepbound [1]
If approved, orforglipron would be the most affordable branded oral GLP-1 option available through Lilly’s direct programs. The $149 entry price point is notably lower than any current injectable option on LillyDirect.
For patients comparing GLP-1 medication types, our GLP-1 drugs list and complete guide covers all currently approved and pending options.
What Are the Most Common Mistakes People Make With These Savings Programs?
Knowing the savings exist is only half the battle. These are the errors that cause people to get rejected or pay more than they should.
Mistake 1: Assuming Medicare disqualifies you from everything Medicare disqualifies you from the commercial Savings Card, but the new $50 Medicare cap means you may actually pay less than commercially insured patients. [1]
Mistake 2: Not checking if your pharmacy participates The Savings Card works at most major retail pharmacies, but not all. Confirm before filling. [6]
Mistake 3: Using the Savings Card without activating it The card must be registered online before the discount applies at the pharmacy. [6]
Mistake 4: Choosing single-dose pens when the multidose pen is cheaper For self-pay patients, the LillyDirect multidose pen ($299–$449) is almost always cheaper than the $499 Savings Card cap for single-dose pens. [1][3]
Mistake 5: Overlooking the Zepbound vial option Zepbound is also available in vial form, which can offer additional savings in some scenarios. See our Zepbound vial vs. pen price comparison for a full breakdown.
Mistake 6: Missing annual limits The Savings Card has both monthly and annual cost caps. Once you hit the annual limit, you pay full price for the remainder of the year. Track your usage. [6]
Frequently Asked Questions
Q: Can I use the Mounjaro Savings Card if I’m taking it for weight loss, not diabetes? A: Mounjaro is FDA-approved for type 2 diabetes, not weight loss. Zepbound is the tirzepatide product approved for weight loss. If your prescription is for weight loss, you need a Zepbound prescription to use the Zepbound Savings Card. [5][6]
Q: Does the $25/month Savings Card price apply to every dose of Zepbound? A: Yes, the $25 minimum applies across all doses for eligible commercially insured patients, but it is subject to monthly and annual program limits. Once those limits are reached, standard cost-sharing applies. [6]
Q: Is LillyDirect available in all 50 states? A: LillyDirect availability depends on state telehealth and pharmacy regulations. Check the LillyDirect website for current state availability before enrolling.
Q: Can I switch from the Savings Card to LillyDirect mid-year? A: Yes, but you should compare the costs carefully. If you’ve been using the Savings Card and switch to LillyDirect, your Savings Card annual limit tracking resets. Consult your prescriber before switching.
Q: What happens if my insurance stops covering Zepbound? A: You can transition to the LillyDirect self-pay program or the uninsured Savings Card option ($499 cap). The LillyDirect multidose pen is typically the better value. [1][3]
Q: Does the new Medicare $50 cap require a specific diagnosis? A: Medicare beneficiaries with obesity or obesity-related comorbidities qualify. The exact diagnostic criteria are determined by your Part D plan under the new agreement. Contact your plan for specifics. [1][4]
Q: When will orforglipron be available through Lilly’s savings programs? A: Orforglipron pricing through LillyDirect and Medicare is announced, but availability depends on FDA approval. Lilly has applied for expedited review. No confirmed approval date is available as of April 2026. [1]
Q: Can I use GoodRx or other discount cards alongside the Lilly Savings Card? A: No. You cannot combine the Lilly Savings Card with other discount programs, coupons, or patient assistance programs at the same time. Use the one that gives you the lowest out-of-pocket cost.
Q: Is there a patient assistance program for people who can’t afford even the reduced prices? A: Eli Lilly’s Lilly Cares Foundation offers assistance for patients who meet income requirements. Visit lillycares.com for current eligibility criteria.
Q: How does the Mounjaro $25 coupon work compared to the Zepbound card? A: The mechanics are similar, but they apply to different medications. For a detailed breakdown of Mounjaro coupon eligibility, see our Mounjaro $25 coupon guide for uninsured patients.
Conclusion: Which Savings Path Is Right for You?
The right savings option depends entirely on your insurance status, and the answer is clearer than most people think:
- Commercial insurance? Enroll in the Savings Card at zepbound.lilly.com/savings. Target: $25/month.
- No insurance? Use LillyDirect for the multidose pen. Target: $299–$449/month.
- Medicare? Contact your Part D plan about the new $50/month cap. Effective April 1, 2026.
- Medicaid? Check with your state program; Medicaid expansion access is being rolled out under the federal agreement.
Your next steps:
- Confirm your insurance status before choosing a program
- Get a valid prescription from your doctor (for Zepbound if your goal is weight loss)
- Enroll in the appropriate savings program before your first fill
- Set a calendar reminder to track your annual Savings Card limit if applicable
- Revisit your options if your insurance changes or if orforglipron receives FDA approval
The Eli Lilly Savings Program for Mounjaro and Zepbound has more pathways in 2026 than ever before. The $50 Medicare cap alone represents a major shift for millions of patients who previously had no affordable access. Use the right program for your situation, activate it before your pharmacy visit, and you’ll avoid the most common and costly mistakes.
For a broader look at all your GLP-1 cost-reduction options, see our best GLP-1 weight loss programs starting from $179/month.
With over 13 years of experience in holistic health blogging, I aim to help you navigate your wellness journey with honest insights, expert-backed advice, and a sprinkle of real-world practicality.
Certified Wellness Writer | Herbal Nutrition Advocate | Wellness Research Enthusiast
